An Update on Invasive Pneumococcal Antibiotic Resistance in Turkey, 2008

References

• Erdem H, Pahsa A. Antibiotic resistance in pathogenic Streptococcus pneumoniae isolates in Turkey J Chemother. 2005; 17 (1): 25–30.
   Google Scholar
• Clinical and Laboratory Standards Institute. Methods for di-lution antimicrobial tests: bacteria that grow aerobically. 7 ed 2006.
   Google Scholar
• Yenisehirli G, Sener B. Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty Mikrobiyol Bul. 2003;37(1–11).
   Google Scholar
• Altun B, Gur D, Kocagoz S, Hascelik G, Unal S. Molecu-lar epidemiology of penicillin resistant Streptococcus pneumo-niae strains in Turkey. A multicenter study. Annals Microbiol. 2006 ; 56 (3): 185–90.
   Web of Science ®Google Scholar
• Senol G, Erer OF, Bicmen C, Aktogu S. Alt solunum yolu infeksiyonlarindan izole edilen S. pneumoniae suslarinin penisi- line karsi direnc oranlari (The penicillin resistance rates of S pneu-moniae strains isolated from lower respiratory tract infections). Toraks Derg. 2001; 2 (3): 10-5.
   Google Scholar
• Kucukbasmaci O, Gonullu N, Aktas Z, Gurol D, Berkiten R. In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. Int J An-timicrob Agents. 2003; 22 (5): 497–501.
   PubMed Web of Science ®Google Scholar
• Tanir G, Karacan C, Topal H, Ozkan S. Streptococcus pneumoniae'nin cocukluk doneminde etken oldugu invazif in-feksiyonlar ye antibiyotiklere karsi direnc durumu (The invasive infections in childhood due to S. pneumoniae and the antibiotic susceptibility patterns). Klimik Derg. 2003; 16 (2): 79-84.
   Google Scholar
• Oncu S, Punar M, Eraksoy H. Comparative activities of beta-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates. Chemotherapy. 2004; 50 (2): 98–100.
   PubMed Web of Science ®Google Scholar
• Sener B, Koseoglu O. Comparative in vitro activity of an-tiribosomal agents on penicillin-susceptible and resistant Strep-tococcus pneumonioe in relation to their resistance genotypes. Int J Med Microbiol 2004; 24 (1): 39–42.
   Google Scholar
• Bicmen M, Gtilay Z. Antibiotic susceptibility patterns and molecular epidemiology of S. pneumoniae in Izmir Turkey. Clin Microbiol Infect. 2003; 9( Suppl 1):356.
   Google Scholar
• Erdem H, Onctil O, cavuslu S, Pahsa A. Sivas bolgesinde hastalik etkeni pnomokoklarda direnc (Antibacterial resistance in invasive pneumococci in Sivas Region). Klimik Derg. 2002; 15 (2): 46–8.
   Google Scholar
• Tuncer I, Arslan U, Findik D, Ural O. Klinik orneklerden izole edilen Streptococcus pneumoniae suslarinda artan penisilin direnci ye bazi antibiyotiklere karsi direnc durumu (Increasing rates of penicillin resistance and nonsusceptibility to various an-timicrobials in invasive S. pneumoniae isolates). Ankem Derg. 2005 19 (1): 35-8.
   Google Scholar
• Gur D, Mulazimoglu L, Unal S. In vitro susceptibility of S. pneumoniae and S. pyogenes to telithromycin and 11 other an-timicrobial agents: Turkish results of e-BASKETT-II surveillance study. Mikrobiyol Bul. 2007; 41 (1): 1-9.
   Google Scholar
• Yalcin I, Gurler N, Alhan E, Yaman A, Turgut M, Celik U. Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001-2004 Eur J Pediatr. 2006; 165 (9): 954–7.
   Google Scholar
• Senol G, Erer OF, Aktogu-Ozkan S. Garenoksasinin alt solunum yolu patojenlerine in-vitro etkinligi (In-vitro efficacy of garenoxacin to lower respiratory pathogens). Klimik Derg. 2006; 19 (1): 28–31.
   Google Scholar
• Sener B, Tunckanat F, Ulusoy S, Tunger A, Soyletir G, Mulazimoglu L, et al. A survey of antibiotic resistance in Strep-tococcus pneumoniae and Haemophilus influenzae in Turkey, 2004-2005. J Antimicrob Chemother. 2007.
   Google Scholar
• Uncu H, colakoglu S, Turunc T, Demiroglu YZ, Asian H. In vitro resistance rates of S. pneumoniae and H. influenzae clinical isolates to the antibiotics used in therapy. Mikrobiyol Bul. 2007; 41 (3): 441-46.
   Google Scholar
• Dilek AR, Korkmaz E, Yilmaz M. Klinik orneklerden izole edilen S. pneumoniae suslarinda penicillin direnci (Pneumococ-cal penicillin resistance in clinical isolates). FU Sag Bil Derg. 2007; 21 (3): 125-28.
   Google Scholar
• Firat M, Ersoy Y, Esel D, Bayraktar M, Caylan R, Durmaz R. Antimicrobial susceptibility and serotype distribution of pneu-mococci strains isolated from meningitis patients Mikrobiyol Bul. 2006; 40 (3): 169–77.
   Google Scholar
• Azap A, Altunsoy A, Memikoglu KA, Balik I. Solunum sis-temi infeksiyonlarindan izole edieln pnomokok suslarinin cesitli antibiyotiklere duyarliliklari (The antibiotic susceptibilities of res-piratory pneumococcal isolates to various antimicrobials). Ankara Univ Tip Fak Mecm. 2004; 57 (2): 63–7.
   Google Scholar
• Oncu S, Erdem H, Pahsa A. Therapeutic options for pneu-mococcal pneumonia in Turkey. Clin Ther. 2005; 27 (6): 674–83.
   PubMed Web of Science ®Google Scholar
• Woodnutt G, Berry V. Efficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1999; 43 (1): 35–40.
   PubMed Web of Science ®Google Scholar
• Chidiac C. Acute community-acquired pneumonia. A re-view of clinical trials. Med Mal Infect 2006;36(11–12).
   Google Scholar
• Paris MM, Ramilo O, McCracken GH. Management of meningitis caused by penicillin-resistant Streptococcus pneu-moniae. Antimicrob Agents Chemother. 1995; 39 (10): 2171–75.
   PubMed Web of Science ®Google Scholar
• Erdem H, Oncu S, Pahsa A. Antimicrobial therapy in pneumococcal meningitis: an epidemiological assessment from Turkey. Int J Infect Dis 2006; 10 (3): 262–3.
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell D, Dean NC. Infectious Diseases Society of Amer-ica/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis. 2007; 44: S000.
   Google Scholar
• Lon JR. What is the clinical impact of macrolide resist-ance? Curr Infect Dis Rep. 2004; 6: 7–12.
   Google Scholar
• Clay KD, Hanson JS, Pope SD, Rissmiller RW, Purdum PP, Banks PM. Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review. Ann Intern Med. 2006; 144: 415–20.
   PubMed Web of Science ®Google Scholar
• Ak O, Benzonana N, Ozer S, Eraksoy H. Emergence of high-level fluoroquinolone-resistant Streptococcus pneumoniae in Turkey. Int J Infect Dis 2003; 7: 288–9.
   PubMedGoogle Scholar
• Lieberman JM. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance. Pediatr Infect Dis J. 2003; 22: 1142–51.
   Google Scholar